PEAK6
VKTX icon

PEAK6’s Viking Therapeutics VKTX Stock Holding History

PEAK6’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6K Buy
+1,221
New +$39.4K ﹤0.01% 2482
2025
Q3 		– Sell
-31,194
Closed -$827K – 3516
2025
Q2 		$827K Buy
31,194
+4,146
+15% +$109K ﹤0.01% 1901
2025
Q1 		$653K Buy
27,048
+25,048
+1,252% +$792K ﹤0.01% 1960
2024
Q4 		$80.5K Buy
+2,000
New +$114K ﹤0.01% 2772

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PEAK6's VKTX Position: Q2 2026 in Review

PEAK6 opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 1,221 shares worth $47.6K. The stake represents ﹤0.01% of the portfolio and ranks #2482 among its holdings. This is a return to the name: PEAK6 previously reported a position in VKTX as recently as Q2 2025.

PEAK6 first reported a position in VKTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $827K in Q2 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • PEAK6 held 1,221 shares of Viking Therapeutics worth $47.6K as of Q2 2026.
  • Viking Therapeutics was a new PEAK6 position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2482 holding.
  • PEAK6 first reported a position in Viking Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • PEAK6's Viking Therapeutics position peaked at $827K in Q2 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.